- Home
- RETO vs ICU Comparison
RETO vs ICU Comparison
Compare RETO & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- ICU
- Stock Information
- Founded
- RETO 1999
- ICU 2018
- Country
- RETO China
- ICU United States
- Employees
- RETO N/A
- ICU N/A
- Industry
- RETO Multi-Sector Companies
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- ICU Health Care
- Exchange
- RETO Nasdaq
- ICU Nasdaq
- Market Cap
- RETO 10.0M
- ICU 10.4M
- IPO Year
- RETO 2017
- ICU N/A
- Fundamental
- Price
- RETO $3.62
- ICU $1.24
- Analyst Decision
- RETO
- ICU
- Analyst Count
- RETO 0
- ICU 0
- Target Price
- RETO N/A
- ICU N/A
- AVG Volume (30 Days)
- RETO 384.7K
- ICU 115.6K
- Earning Date
- RETO 06-26-2025
- ICU 05-14-2025
- Dividend Yield
- RETO N/A
- ICU N/A
- EPS Growth
- RETO N/A
- ICU N/A
- EPS
- RETO N/A
- ICU N/A
- Revenue
- RETO $1,828,976.00
- ICU $135,000.00
- Revenue This Year
- RETO N/A
- ICU $648.15
- Revenue Next Year
- RETO N/A
- ICU $100.00
- P/E Ratio
- RETO N/A
- ICU N/A
- Revenue Growth
- RETO N/A
- ICU N/A
- 52 Week Low
- RETO $0.33
- ICU $1.11
- 52 Week High
- RETO $7.10
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- RETO 53.52
- ICU 37.68
- Support Level
- RETO $3.02
- ICU $1.22
- Resistance Level
- RETO $3.75
- ICU $1.30
- Average True Range (ATR)
- RETO 0.36
- ICU 0.06
- MACD
- RETO 0.01
- ICU 0.02
- Stochastic Oscillator
- RETO 55.56
- ICU 33.33
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.